Neill J. Liptrott

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

Ruben C. Hartkoorn, Wai San Kwan, Victoria Shallcross et al. · Pharmacogenetics and Genomics · 2010 · 175 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction

Sudeep Pushpakom, Neill J. Liptrott, Sonia Rodríguez‐Nóvoa et al. · The Journal of Infectious Diseases · 2011 · 107 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro–In Vivo Correlation

Tom O. McDonald, Marco Giardiello, Philip Martin et al. · Advanced Healthcare Materials · 2013 · 89 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies

Marco Giardiello, Neill J. Liptrott, Tom O. McDonald et al. · Nature Communications · 2016 · 63 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16

Raltegravir Is a Substrate for SLC22A6: a Putative Mechanism for the Interaction between Raltegravir and Tenofovir

Darren Moss, Wai San Kwan, Neill J. Liptrott et al. · Antimicrobial Agents and Chemotherapy · 2010 · 62 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17